SPDR S&P Pharmaceuticals ETF
XPH
XPH
78 hedge funds and large institutions have $308M invested in SPDR S&P Pharmaceuticals ETF in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.29% less ownership
Funds ownership: 59.26% → 58.97% (-0.29%)
42% less call options, than puts
Call options by funds: $497K | Put options by funds: $864K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
78
Holding in Top 10
1
Calls
$497K
Puts
$864K
Top Buyers
| 1 | +$5.4M | |
| 2 | +$4.66M | |
| 3 | +$2.49M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.4M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.38M |
Top Sellers
| 1 | -$4.05M | |
| 2 | -$1.38M | |
| 3 | -$1.23M | |
| 4 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
-$808K |
| 5 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$617K |